0001127602-21-012232.txt : 20210329 0001127602-21-012232.hdr.sgml : 20210329 20210329163748 ACCESSION NUMBER: 0001127602-21-012232 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210325 FILED AS OF DATE: 20210329 DATE AS OF CHANGE: 20210329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARCUS JOEL S CENTRAL INDEX KEY: 0001216955 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39062 FILM NUMBER: 21782154 MAIL ADDRESS: STREET 1: C/O ALEXANDRIA REAL ESTATE EQUITIES, INC STREET 2: 26 NORTH EUCLID AVENUE CITY: PASADENA STATE: CA ZIP: 91101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Frequency Therapeutics, Inc. CENTRAL INDEX KEY: 0001703647 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472324450 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19 PRESIDENTIAL WAY, SUITE 203 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 781-315-4600 MAIL ADDRESS: STREET 1: 19 PRESIDENTIAL WAY, SUITE 203 CITY: WOBURN STATE: MA ZIP: 01801 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-03-25 0001703647 Frequency Therapeutics, Inc. FREQ 0001216955 MARCUS JOEL S C/O FREQUENCY THERAPEUTICS, INC., 19 PRESIDENTIAL WAY, 2ND FLOOR WOBURN MA 01801 1 Common Stock 2021-03-25 4 M 0 37116 3.37 A 307116 D Common Stock 1011730 I Alexandria Venture Investments, LLC Stock Option 3.37 2021-03-25 4 M 0 37116 0 D 2029-05-19 Common Stock 37116 0 D Represents securities held of record by Alexandria Venture Investments, LLC ("Alexandria"). Alexandria Real Estate Equities, Inc. is the managing member of Alexandria. Each of Alexandria and Alexandria Real Estate Equities, Inc. has shared voting and investment power with respect to the shares owned by Alexandria. The reporting person is the Executive Chairman of Alexandria Real Estate Equities, Inc. and may therefore be deemed to have voting and investment power with respect to the shares owned by Alexandria. Each of the reporting person and Alexandria Real Estate Equities, Inc. disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein. The option became fully vested and exercisable on December 26, 2020. /s/ Michael D. Bookman, Attorney-in-Fact for Joel S. Marcus 2021-03-29